Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiki Sakai

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Pharmacy and Pharmacology|July 14, 2011
Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocityMai Hazekawa, Yoshiki Sakai, Miyako Yoshida, et al.
Biomedical Research (Tokyo, Japan)|November 6, 2013
Suppression of fibrogenic gene expression and liver fibrosis using a synthetic prostacyclin agonistQing Xu, Katsuya Sakai, Yoshinori Suzuki, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 13, 2009
Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamstersYoichiro Hirata, Takeshi Soeki, Masashi Akaike, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2020
Synthetic Prostacyclin Agonist Attenuates Pressure-Overloaded Cardiac Fibrosis by Inhibiting FMTKenta Masada, Shigeru Miyagawa, Yoshiki Sakai, et al.
International Heart Journal|March 9, 2012
A prostacycline analog prevents chronic myocardial remodeling in murine cardiac allograftsJun-ichi Suzuki, Masahito Ogawa, Yoshiki Sakai, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 17, 2021
BRCA1-BARD1 Regulates Axon Regeneration in Concert with the Gqα-DAG Signaling NetworkYoshiki Sakai, Hiroshi Hanafusa, Tatsuhiro Shimizu, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 16, 2013
Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heartKazuhiko Ishimaru, Shigeru Miyagawa, Satsuki Fukushima, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 14, 2011
Suppression of acute hepatic injury by a synthetic prostacyclin agonist through hepatocyte growth factor expressionQing Xu, Mizuho Nakayama, Yoshinori Suzuki, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
Administration of Slow-Release Synthetic Prostacyclin Agonist Promoted Angiogenesis and Skeletal Muscle Regeneration for Limb IschemiaTakaya Nakagawa, Shigeru Miyagawa, Takashi Shibuya, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 25, 2021
CDK14 Promotes Axon Regeneration by Regulating the Noncanonical Wnt Signaling Pathway in a Kinase-Independent MannerNaoki Hisamoto, Yoshiki Sakai, Kohei Ohta, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacy and Pharmacology|July 14, 2011
Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocityMai Hazekawa, Yoshiki Sakai, Miyako Yoshida, et al.
Biomedical Research (Tokyo, Japan)|November 6, 2013
Suppression of fibrogenic gene expression and liver fibrosis using a synthetic prostacyclin agonistQing Xu, Katsuya Sakai, Yoshinori Suzuki, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 13, 2009
Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamstersYoichiro Hirata, Takeshi Soeki, Masashi Akaike, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2020
Synthetic Prostacyclin Agonist Attenuates Pressure-Overloaded Cardiac Fibrosis by Inhibiting FMTKenta Masada, Shigeru Miyagawa, Yoshiki Sakai, et al.
International Heart Journal|March 9, 2012
A prostacycline analog prevents chronic myocardial remodeling in murine cardiac allograftsJun-ichi Suzuki, Masahito Ogawa, Yoshiki Sakai, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 17, 2021
BRCA1-BARD1 Regulates Axon Regeneration in Concert with the Gqα-DAG Signaling NetworkYoshiki Sakai, Hiroshi Hanafusa, Tatsuhiro Shimizu, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 16, 2013
Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heartKazuhiko Ishimaru, Shigeru Miyagawa, Satsuki Fukushima, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 14, 2011
Suppression of acute hepatic injury by a synthetic prostacyclin agonist through hepatocyte growth factor expressionQing Xu, Mizuho Nakayama, Yoshinori Suzuki, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
Administration of Slow-Release Synthetic Prostacyclin Agonist Promoted Angiogenesis and Skeletal Muscle Regeneration for Limb IschemiaTakaya Nakagawa, Shigeru Miyagawa, Takashi Shibuya, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 25, 2021
CDK14 Promotes Axon Regeneration by Regulating the Noncanonical Wnt Signaling Pathway in a Kinase-Independent MannerNaoki Hisamoto, Yoshiki Sakai, Kohei Ohta, et al.
Pageof 6